| P50 | author | Giovanna Muscogiuri | Q51281723 |
| P2093 | author name string | K Clark | |
| | R L Reddick | |
| | F Jimenez | |
| | C A Estrada | |
| | S S Ahuja | |
| | N Musi | |
| | G Sorice | |
| | H G Martinez | |
| | M P Quinones | |
| P2860 | cites work | Obesity is associated with macrophage accumulation in adipose tissue | Q27860976 |
| | Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice | Q28585385 |
| | CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 c | Q28588634 |
| | Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. | Q28590391 |
| | MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity | Q29614283 |
| | Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey | Q29614468 |
| | Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E | Q29615236 |
| | The many roles of chemokines and chemokine receptors in inflammation | Q29618880 |
| | CCR2 modulates inflammatory and metabolic effects of high-fat feeding | Q29622869 |
| | Leukocyte recruitment and vascular injury in diabetic nephropathy | Q30439127 |
| | Hypercholesterolemia reduces collateral artery growth more dominantly than hyperglycemia or insulin resistance in mice | Q30811222 |
| | CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice | Q30891436 |
| | CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney. | Q33246091 |
| | Body fat distribution and inflammation among obese older adults with and without metabolic syndrome | Q34985484 |
| | Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence | Q36177005 |
| | Renal redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and diabetic nephropathy: paying homage to the podocyte. | Q36279580 |
| | The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease | Q36380101 |
| | The metabolic syndrome. Beyond the insulin resistance syndrome. | Q36484070 |
| | Mechanisms linking diabetes mellitus to the development of atherosclerosis: a role for endoplasmic reticulum stress and glycogen synthase kinase-3. | Q36538348 |
| | Chemokine regulation of atherosclerosis | Q36747915 |
| | Proteinuria in diabetes: bystander or pathway to cardiorenal disease? | Q37807211 |
| | Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice | Q38314767 |
| | Glycogen synthase kinase 3beta is a novel regulator of high glucose- and high insulin-induced extracellular matrix protein synthesis in renal proximal tubular epithelial cells | Q39950939 |
| | Macrophage-secreted factors induce adipocyte inflammation and insulin resistance | Q40326610 |
| | Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle | Q42522942 |
| | Loss of insulin-mediated microvascular perfusion in skeletal muscle is associated with the development of insulin resistance. | Q42962656 |
| | Atherosclerotic mice exhibit systemic inflammation in periadventitial and visceral adipose tissue, liver, and pancreatic islets. | Q45989922 |
| | Fenofibrate ameliorates diabetic and dyslipidemic profiles in KKAy mice partly via down-regulation of 11beta-HSD1, PEPCK and DGAT2. Comparison of PPARalpha, PPARgamma, and liver x receptor agonists | Q46107767 |
| | Inhibition of CCR2 ameliorates insulin resistance and hepatic steatosis in db/db mice. | Q46345972 |
| | Morphometric analysis of effects of angiotensin II on glomerular structure in rats | Q46427323 |
| | Genetics of obesity in KK mouse and effects of A(y) allele on quantitative regulation | Q47869515 |
| | Nodular thickening of peritubular basement membranes in diabetic kidneys | Q50958249 |
| | Involvement of apolipoprotein E in excess fat accumulation and insulin resistance | Q64377348 |
| | Adiponectin replenishment ameliorates obesity-related hypertension | Q64377846 |
| | Mesangial thickening and nodular glomerular sclerosis in diabetes mellitus and other diseases | Q70512262 |
| | General Survey of Diabetic Features of Yellow KK Mice | Q71566421 |
| | Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice | Q77340592 |
| | CC chemokine receptor 5 influences late-stage atherosclerosis | Q80232714 |
| | Trends in incidence of treated end-stage renal disease, overall and by primary renal disease, in persons aged 20-64 years in Europe, Canada and the Asia-Pacific region, 1998-2002 | Q81095258 |
| | Pioglitazone mitigates renal glomerular vascular changes in high-fat, high-calorie-induced type 2 diabetes mellitus | Q83143491 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 10 | |
| P921 | main subject | metabolic syndrome | Q657193 |
| P304 | page(s) | 2660-2668 | |
| P577 | publication date | 2011-07-21 | |
| P1433 | published in | Diabetologia | Q5270140 |
| P1476 | title | Critical role of chemokine (C-C motif) receptor 2 (CCR2) in the KKAy + Apoe -/- mouse model of the metabolic syndrome | |
| P478 | volume | 54 | |